Hairong M. Huang

Beijing, 100045, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Research progress on the association between prenatal nutritional factors and autism spectrum disorder

Research progress on the association between prenatal nutritional factors and autism spectrum disorder

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: September 16, 2025

Xpert-Ultra for diagnosing asymptomatic tuberculosis.

Xpert-Ultra for diagnosing asymptomatic tuberculosis.

Journal: The Lancet. Infectious diseases

Published: September 05, 2025

A phase therapy regimen containing clofazimine manifested high efficacy in treating Mycobacterium abscessus pulmonary disease.

A phase therapy regimen containing clofazimine manifested high efficacy in treating Mycobacterium abscessus pulmonary disease.

Journal: BMC pulmonary medicine

Published: August 18, 2025

Nutrition intervention in the management of attention deficit hyperactivity disorder in children

Nutrition intervention in the management of attention deficit hyperactivity disorder in children

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: May 15, 2025

Progress in nutritional management of children with autism spectrum disorder comorbidity avoidant/restrictive food intake disorder

Progress in nutritional management of children with autism spectrum disorder comorbidity avoidant/restrictive food intake disorder

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: January 23, 2025

Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis.

Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis.

Journal: Clinical pharmacokinetics

Published: July 01, 2024

Drug repurposing: An antidiabetic drug Ipragliflozin as Mycobacterium tuberculosis sirtuin-like protein inhibitor that synergizes with anti-tuberculosis drug isoniazid.

Drug repurposing: An antidiabetic drug Ipragliflozin as Mycobacterium tuberculosis sirtuin-like protein inhibitor that synergizes with anti-tuberculosis drug isoniazid.

Journal: International journal of biological macromolecules

Published: June 29, 2024

Corrigendum to "Tuberculosis-targeted next-generation sequencing and machine learning: An ultrasensitive diagnostic strategy for paucibacillary pulmonary tuberculosis and tuberculous meningitis" [Clin. Chim. Acta 553 (2024) 117697].

Corrigendum to "Tuberculosis-targeted next-generation sequencing and machine learning: An ultrasensitive diagnostic strategy for paucibacillary pulmonary tuberculosis and tuberculous meningitis" [Clin. Chim. Acta 553 (2024) 117697].

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: May 10, 2024

Tuberculosis-targeted next-generation sequencing and machine learning: An ultrasensitive diagnostic strategy for paucibacillary pulmonary tuberculosis and tuberculous meningitis.

Tuberculosis-targeted next-generation sequencing and machine learning: An ultrasensitive diagnostic strategy for paucibacillary pulmonary tuberculosis and tuberculous meningitis.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: September 12, 2023

Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex-pulmonary disease in patients unsuitable for standard treatment regimen.

Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex-pulmonary disease in patients unsuitable for standard treatment regimen.

Journal: International journal of antimicrobial agents

Published: September 04, 2023

Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients.

Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients.

Journal: Journal of global antimicrobial resistance

Published: November 08, 2022

Xpert MTB/RIF Ultra outperformed the Xpert assay in tuberculosis lymphadenitis diagnosis: a prospective head-to-head cohort study.

Xpert MTB/RIF Ultra outperformed the Xpert assay in tuberculosis lymphadenitis diagnosis: a prospective head-to-head cohort study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: June 20, 2022

Showing 1-12 of 72

Last Updated: 09/26/2026